News GSK plc

Stocks

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 09:05:12 16/07/2026 pm IST			5-day change	1st Jan Change
1,956.00 ^GBX	+2.06%		-0.18%	+7.21%

09:24pm	India's Serum Institute partners with Gates MRI to make experimental TB vaccine	RE
15/07	GSK Completes $10.6 Billion Acquisition of Nuvalent	MT

All News

Mentions Relevance

09:24pm	India's Serum Institute partners with Gates MRI to make experimental TB vaccine	RE
15/07	GSK Completes $10.6 Billion Acquisition of Nuvalent	MT
15/07	What If A Shingles Jab Could Also Protect Your Brain?	AQ
15/07	GSK completes USD10.6 billion acquisition of Nuvalent	AN
15/07	GSK Closes $10.6 Billion Purchase of Nuvalent	MT
15/07	GSK : completes acquisition of Nuvalent, Inc.	PU
13/07	GSK : UBS remains Neutral	ZD
13/07	GSK Plc Announces Positive Interim Results From AZUR-1 Phase II Trial Of Jemperli In dMMR/MSI-H Locally Advanced Rectal Cancer	CI
13/07	GSK Says Jemperli Poised to Transform Rectal Cancer Care After Positive Interim Trial Results	MT
13/07	GSK Says Mid-Stage Trial of Jemperli Met Main Goal in Rectal Cancer	MT
13/07	GSK posts encouraging data for bowel cancer treatment Jemperli	AN
13/07	GSK's Jemperli meets main goal in mid-stage rectal cancer trial	RE
13/07	GSK hails cancer trial success; Plus500 backs outlook	AN
13/07	GSK Reports Positive Interim Data for Jemperli in Mid-stage Rectal Cancer Trial	MT
13/07	GSK's cancer drug Jemperli meets main goal in mid-stage rectal cancer trial	RE
13/07	GSK : Jemperli (dostarlimab) achieves sustained clinical complete responses in dMMR/MSI-H locally advanced rectal cancer	PU
13/07	GSK : JP Morgan remains a Sell rating	ZD
10/07	GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial	AN
10/07	GSK, Hansoh's targeted cancer drug hits main survival goal in China trial	RE
10/07	GSK Licensor Hansoh Reports Positive Phase 3 Results for Risvutatug Rezetecan in China	MT
10/07	GSK's Antibody-drug Conjugate for Small-cell Lung Cancer Meets Primary Endpoint in Late-stage China Study	MT
10/07	GSK : licensor Hansoh Pharma announces positive phase III results for Ris-Rez in China patient population	PU
09/07	Gsk plc Announces Appointment of Roy Jakobs to Non-Executive Director, Effective July 13, 2026	CI
09/07	GSK adds Royal Philips' Chief Executive Jakobs to board	AN
09/07	GSK : Roy Jakobs to join GSK Board as Non-Executive Director	PU